Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
about
Clinical and Histopathological Characteristics between Familial and Sporadic Melanoma in Barcelona, Spain.Li-Fraumeni syndrome: cancer risk assessment and clinical management.Characterization of patients at high risk of melanoma in Austria.Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome.
P2860
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
@ast
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
@en
type
label
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
@ast
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
@en
prefLabel
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
@ast
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
@en
P2093
P2860
P1476
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families
@en
P2093
Femke A de Snoo
Hein Putter
Jasper I van der Rhee
Nicole A Kukutsch
Wilma Bergman
Wolter J Mooi
P2860
P304
P356
10.1016/J.JAAD.2010.06.067
P407
P577
2011-05-12T00:00:00Z